MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 19 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01710-07v1
28/9/3076    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laoukili, J.
Right arrow Articles by Medema, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laoukili, J.
Right arrow Articles by Medema, R. H.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01710-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Activation of FoxM1 during G2 requires CyclinA/Cdk-dependent relief of auto-repression by the FoxM1 N-terminal domain

Jamila Laoukili*, Monica Alvarez, Lars A.T. Meijer, Marie Stahl, Shabaz Mohammed, Livio Kleij, Albert J.R. Heck, and René H. Medema*

Department of Medical Oncology, Laboratory of Experimental Oncology, University Medical Center Utrecht, the Netherlands; Department of Human Genetics, Academic Medical Center (AMC), University of Amsterdam, the Netherlands; Department of Physiological Chemistry and Centre for Biomedical Genetics, University Medical Center Utrecht, the Netherlands; Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands

* To whom correspondence should be addressed. Email: j.laoukili{at}amc.uva.nl. r.h.medema{at}umcutrecht.nl.


   Abstract

The Forkhead transcription factor FoxM1 is an important regulator of gene expression during the G2-phase. Here, we show that FoxM1 transcriptional activity is kept low during G1/S through the action of its N-terminal auto-inhibitory domain. We find that CyclinA/cdk complexes are required to phosphorylate and activate FoxM1 during G2-phase. Deletion of the N-terminal auto-inhibitory region of FoxM1 generates a mutant of FoxM1 ({Delta} N-FoxM1) that is active throughout the cell cycle and no longer depends on cyclinA for its activation. Mutation of two CyclinA/cdk sites in the C-terminal transactivation domain (TAD) leads to inactivation of full-length FoxM1, but does not affect the transcriptional activity of the {Delta} N-FoxM1 mutant. We show that the intramolecular interaction of the N- and C-terminal domains depends on two RXL/LXL-motifs in the C-terminus of FoxM1. Mutation of these domains leads to a similar gain-of-function as deletion of the N-terminal repressor domain. Based on these observations we propose a model in which FoxM1 is kept inactive during the G1/S transition through the action of the N-terminal auto-repressor domain, while phosphorylation by cyclinA/cdk complexes during G2 results in relief of inhibition by the N-terminus allowing activation of FoxM1-mediated gene transcription.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.